Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: Preliminary analysis

Journal of Urology

Volumn 190, Issue 4, 2013, Pages 1213-1217

  Lee, Dong Hoon ^a   Koo, Kyo Chul ^a   Lee, Seung Hwan ^a   Rha, Koon Ho ^a   Choi, Young Deuk ^a   Hong, Sung Joon ^a   Chung, Byung Ha ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

diffusion magnetic resonance imaging; prostatic neoplasms; watchful waiting

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TUMOR VOLUME;

ACTIVE SURVEILLANCE; ADC; APPARENT DIFFUSION COEFFICIENT; AS; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING; DW-MRI; ECE; EXTRACAPSULAR EXTENSION; MAGNETIC RESONANCE IMAGING; MRI; PRIAS; PROSTATE CANCER RESEARCH INTERNATIONAL: ACTIVE SURVEILLANCE; PROSTATE SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSA; PSA DENSITY; PSAD; RADICAL PROSTATECTOMY; RP; SEMINAL VESICLE INVASION; SVI; WATCHFUL WAITING;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR BURDEN; WATCHFUL WAITING;

EID: 84883781432     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.03.127     Document Type: Article

References (20)

1. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
2. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
3. D.H. Lee, H.B. Jung, and S.H. Lee Comparison of pathological outcomes of active surveillance candidates who underwent radical prostatectomy using contemporary protocols at a high-volume Korean center Jpn J Clin Oncol 42 2012 1079
4. V. Iremashvili, L. Pelaez, and M. Manoharan Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols Eur Urol 62 2012 462
5. J.J. Tosoian, B.J. Trock, and P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185
6. C.H. Tan, W. Wei, and V. Johnson Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis AJR Am J Roentgenol 199 2012 822
7. M.A. Haider, T.H. van der Kwast, and J. Tanguay Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 189 2007 323
8. K. Kitajima, Y. Kaji, and Y. Fukabori Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging J Magn Reson Imaging 31 2010 625
9. T. Hambrock, D.M. Somford, and H.J. Huisman Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer Radiology 259 2011 453
10. H.A. Vargas, O. Akin, and T. Franiel Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness Radiology 259 2011 775
11. Y. Mazaheri, H. Hricak, and S.W. Fine Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume Radiology 252 2009 449
12. N.J. van As, N.M. de Souza, and S.F. Riches A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance Eur Urol 56 2009 981
13. N.M. deSouza, S.F. Riches, and N.J. Vanas Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer Clin Radiol 63 2008 774
14. K.W. Doo, D.J. Sung, and B.J. Park Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI Eur Radiol 22 2012 1812
15. A.S. Duffield, T.K. Lee, and H. Miyamoto Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274
16. N. Lawrentschuk, M.A. Haider, and N. Daljeet 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging BJU Int 105 2010 1231
17. B. Turkbey, H. Mani, and O. Aras Correlation of magnetic resonance imaging tumor volume with histopathology J Urol 188 2012 1157
18. R. Mizuno, J. Nakashima, and M. Mukai Maximum tumor diameter is a simple and valuable index associated with the local extent of disease in clinically localized prostate cancer Int J Urol 13 2006 951
19. D. Margel, S.A. Yap, and N. Lawrentschuk Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study J Urol 187 2012 1247
20. T. Metens, D. Miranda, and J. Absil What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 22 2012 703